510(k) K031563
K031563 is an FDA 510(k) premarket notification submitted by The Binding Site, Ltd. for the device "BINDAZYME CLQ CIC EIA KIT". The FDA issued a decision of Substantially Equivalent on September 10, 2003. The device falls under product code DAK (Complement C1q, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5240. The Binding Site, Ltd. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 10, 2003
- Date Received
- May 19, 2003
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Complement C1q, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5240
- Review Panel
- IM
- Submission Type